EUDA Health Holdings Limited
NASDAQ:EUDAMedical - Care Facilities
+$2.20 today
- Market cap
- $53.00M
- Beta
- 0.59
- P/E (TTM)
- -7.9
- EPS (TTM)
- -$1.79
Volume 0.04M
Average 0.02M
EUDA Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
EUDA Health Holdings LimitedNASDAQ: EUDA
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents rises 107.2% from a year ago
Cash & equivalents stood at $365.9K at the end of Q2 FY2026, up 107.2% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +81.7% a year.
Context
- Cash & equivalents amounted to 3.8% of total assets at the end of Q2 FY2026, down 4.5 pp from a year earlier.
- Cash & equivalents increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +107.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 345.15K USD
- Year-over-year change
- +45.3%
- 4-year CAGR
- +16.1%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 345.15K | +45.3% |
| FY2024 | 2024-12-31 | 237.61K | +25.7% |
| FY2023 | 2023-12-31 | 189.01K | +228.5% |
| FY2022 | 2022-12-31 | 57.54K | -69.7% |
| FY2021 | 2021-12-31 | 190K | — |
Cash & Equivalents vs competitors
How EUDA compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +107.2% is the 2nd highest of 8, against a peer median of +23.2%.
- Cash & equivalents amounts to 3.8% of total assets for EUDA, versus a peer median of 55.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $179.21M USD | -19.4% | -30.3% | 55.0% | |
| Mar 2026 | $99.37M USD | +28.7% | -16.4% | 69.1% | |
| Mar 2026 | $63.17M USD | +50.0% | +18.3% | 63.6% | |
| Mar 2026 | $53.65M USD | -1.1% | +5.0% | 24.5% | |
| Mar 2026 | $40.78M USD | +23.2% | -33.3% | 67.6% | |
| Mar 2026 | $10.01M USD | -3.4% | +2.5% | 12.6% | |
| Mar 2026 | CA$1.31M CAD | +975.2% | -49.9% | 8.6% | |
| Jun 2026 | $365.9K USD | +107.2% | +81.7% | 3.8% | |
| Peer median (excluding EUDA) | — | +23.2% | -16.4% | 55.0% | |
Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 190K | 57.54K | 189.01K | 237.61K | 345.15K |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 4.09M | 192.85K | 239.19K | 170.27K | 334.2K |
| Inventory | 0 | 648.16K | 0 | 128.98K | 2.84K |
| Other Current Assets | 2.8K | 24.12M | 295.25K | 226.03K | 357.18K |
| Total Current Assets | 4.35M | 25.03M | 723.44K | 762.88K | 1.04M |
| Property, Plant & Equipment (Net) | 161.16K | 124.5K | 206.99K | 316.26K | 332.29K |
| Goodwill | 992.69K | 0 | 0 | 0 | 0 |
| Intangible Assets | 289.96K | 0 | 0 | 337.3K | 161.43K |
| Long-term Investments | 2.2M | 0 | 0 | 0 | 0 |
| Tax Assets | (2.2M) | 0 | 0 | 32.4K | 0 |
| Other Non-current Assets | 2.2M | 478.06K | 380.07K | 281.38K | 183.47K |
| Total Non-current Assets | 3.65M | 602.56K | 587.07K | 967.34K | 677.2K |
| Total Assets | 8M | 25.63M | 1.31M | 1.73M | 1.72M |
| Account Payables | 2.82M | 1.46M | 1.29K | 25.89K | 14.15K |
| Short-term Debt | 353.73K | 3.57M | 3.17M | 1.04M | 2.2M |
| Tax Payables | 307.34K | 186.15K | 208.66K | 0 | 85.52K |
| Deferred Revenue | 0 | (3.69M) | 0 | 477.92K | 522.03K |
| Other Current Liabilities | 3.82M | 25.14M | 4.6M | (624) | 125K |
| Total Current Liabilities | 7.32M | 29.12M | 8.72M | 4.14M | 5.84M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 49.29K | 0 | 0 | 76.7K | 81.08K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 32.4K | 0 |
| Total Non-current Liabilities | 82.95K | 15.02K | 75.11K | 160.91K | 148.55K |
| Total Liabilities | 7.4M | 29.14M | 8.79M | 4.3M | 5.98M |
| Common Stock | 334.86K | 21.31M | 27.43M | 47.81M | 48.83M |
| Retained Earnings | 180.33K | (24.7M) | (34.74M) | (50.1M) | (52.87M) |
| Accumulated OCI | 6.04K | (125.69K) | (185.47K) | (260K) | (210.99K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 78.82K | 13.48K | 16.62K | (19.01K) | (12.58K) |
| Total Equity | 600.05K | (3.51M) | (7.48M) | (2.57M) | (4.27M) |
| Total Debt | 462.31K | 3.63M | 3.37M | 1.27M | 2.4M |
| Net Debt | 272.31K | 3.57M | 3.19M | 1.04M | 2.06M |
EUDA Health Holdings Limited
NASDAQ:EUDA
Intrinsic Alpha fair value
Locked
Current Price
$17.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.